topotecan has been researched along with Neuroectodermal Tumors, Primitive in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brabetz, S; Chan, JA; Herold-Mende, C; Kool, M; Korshunov, A; Mack, N; Milde, T; Pfister, SM; Schmidt, C; Schubert, NA; Schwalm, B; Selt, F; Witt, O | 1 |
| Allen, JC; Belasco, JB; Fisher, PG; Janss, AJ; Minturn, JE; Patti, R; Phillips, PC | 1 |
| Frazier, L; Neff, T; Salgado, C; Vanderveen, D; Vargas, SO | 1 |
| Adams, R; Albritton, K; Coffin, C; Goldsby, R; Pulsipher, M; Wagner, L | 1 |
| Ashley, D; Chintagumpala, M; Fouladi, M; Gajjar, A; Houghton, PJ; Iacono, LC; Kellie, SJ; Kirstein, MN; Seele, LG; Stewart, CF; Wallace, D; Zamboni, WC | 1 |
| Díaz, MA; González-Vicent, M; Lassaletta, A; Madero, L; Pérez-Martínez, A; Sevilla, J | 1 |
| Adamson, PC; Blaney, SM; Bradfield, S; Franklin, J; Hawkins, DS; Krailo, M; Reaman, G; Whitlock, JA | 1 |
| Ashley, D; Benaim, E; Bowman, L; Gajjar, A; Heideman, R; Jones-Wallace, D; Kellie, SJ; Krance, R; Patel, A; Strother, D; Thompson, S | 1 |
| Bowman, LC; Cunningham, JM; Gajjar, AJ; Houghton, PJ; Houston, JA; Hunt, D; Richardson, SL; Stewart, CF; Yee, GC; Yeoh, EJ | 1 |
5 trial(s) available for topotecan and Neuroectodermal Tumors, Primitive
| Article | Year |
|---|---|
A phase II study of metronomic oral topotecan for recurrent childhood brain tumors.
Topics: Brain Neoplasms; Brain Stem Neoplasms; Child; Disease-Free Survival; Ependymoma; Female; Glioma; Humans; Male; Neuroectodermal Tumors, Primitive; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome | 2011 |
Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor.
Topics: Adolescent; Adult; Antineoplastic Agents; Area Under Curve; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Female; Humans; Infusions, Intravenous; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Risk Factors; Topotecan; Treatment Outcome | 2004 |
High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Male; Medulloblastoma; Melphalan; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Supratentorial Neoplasms; Thiotepa; Topotecan; Transplantation, Autologous; Treatment Outcome | 2005 |
Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study.
Topics: Adolescent; Adult; Astrocytoma; Child; Child, Preschool; Dose-Response Relationship, Drug; Fatigue; Female; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Neoplasm Recurrence, Local; Neuroblastoma; Neuroectodermal Tumors, Primitive; Neutropenia; Recurrence; Sarcoma; Survival Rate; Thrombocytopenia; Time Factors; Topotecan; Treatment Outcome | 2006 |
Topotecan-filgrastim combination is an effective regimen for mobilizing peripheral blood stem cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Costs and Cost Analysis; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Radiotherapy, Adjuvant; Recombinant Proteins; Retrospective Studies; Therapeutic Equivalency; Topotecan | 2001 |
4 other study(ies) available for topotecan and Neuroectodermal Tumors, Primitive
| Article | Year |
|---|---|
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Proliferation; Child, Preschool; Dactinomycin; Female; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Pteridines; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
An unusual case of congenital primitive neuroectodermal tumor with ocular metastasis.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cyclophosphamide; Doxorubicin; Eye Neoplasms; Face; Fatal Outcome; Humans; Infant, Newborn; Male; Neuroectodermal Tumors, Primitive; Soft Tissue Neoplasms; Topotecan; Vincristine | 2012 |
Unexpected pleural effusions in 3 pediatric patients treated with STI-571.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Marrow Transplantation; Camptothecin; Child; Combined Modality Therapy; Edema; Enzyme Inhibitors; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Irinotecan; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemic Infiltration; Lung Neoplasms; Male; Neoplasm Proteins; Neuroectodermal Tumors, Primitive; Piperazines; Pleural Effusion; Proto-Oncogene Proteins c-kit; Pyrimidines; Remission Induction; Sarcoma, Ewing; Testis; Topotecan | 2002 |
Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Feasibility Studies; Female; Humans; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Stem Cells; Topotecan; Vincristine | 2001 |